Bayer BioScience GmbH (Potsdam, Germany) has patented DNA sequences coding for proteins having the enzymatic activity of an amylosucrase
which allows the synthesis of linear .alpha.-1,4 glucans from the
substrate sucrose by bacteria, fungi and plants or in cell-free systems.
The invention furthermore describes plasmids and bacteria containing
these DNA sequences as well as processes for the production of plants
and microorganisms capable of intracellularly or extracellularly
expressing a polypeptide having amylosucrase activity. The invention
furthermore relates to the production of pure fructose using proteins
exhibiting the enzymatic activity of amylosucrase. (US 6,818,421)
Printer friendly
Cite/link
Email
Feedback